Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nizatidine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nizatidine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(nizatidine)		Trials
(nizatidine)		Recent Studies (post-2010) (nizatidine)
9,15618755233712942

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ackerman, Z; Eliakim, R; Karmeli, F; Rachmilewitz, D; Stalnikowicz, R1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nizatidine

ArticleYear
The effect of nizatidine on duodenal ulcer healing and on mucosal inflammatory mediators.
    Israel journal of medical sciences, 1994, Volume: 30, Issue:10

    Topics: Adult; Aged; Dinoprostone; Double-Blind Method; Duodenal Ulcer; Female; Gastric Mucosa; Gastroscopy; Humans; Leukotriene B4; Leukotriene C4; Male; Middle Aged; Nizatidine; Platelet Activating Factor; Radioimmunoassay; Risk Factors

1994